Southpoint Capital Advisors LP insider trades
Open-market stock purchases and sales by Southpoint Capital Advisors LP, 10% Owner at Fennec Pharmaceuticals Inc, from SEC Form 4 filings since Feb 21, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +65%.
Get free alerts when Southpoint Capital Advisors LP files a new trade →